Novo Nordisk to sell weight-loss drug for $499
Digest more
The Ozempic price cut could appease US President Donald Trump, who has pushed for drug companies to lower their prices.
The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a [form of liver disease](
Novo Nordisk has halved the US price for Ozempic for people who cannot access it on health insurance and offered it for home delivery as the Trump administration pushes for lower drug prices and more direct sales.